Project Grant R43GM122156

The National Science Foundation (NSF) awarded a $304,984 Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Treysta Medical Technologies LLC in Gainesville, FL. The grant supports the development of a novel burn care therapy to prevent fibrotic pathologies and improve outcomes for burn injury survivors. The project aims to integrate a three-part sequence of topical anti-scarring therapeutics with a purpose-built dressing designed for serious burn...

This $305,000 federal Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program aims to develop a novel bioactive hydrogel dressing with a porous surface for the treatment of second-degree burn wounds. The project, awarded to LF Printech LLC, is focused on addressing critical challenges in burn wound management by creating a dressing that can accelerate natural healing, reduce pain and trauma associated with dressing changes,...

This Project Grant award, made by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports the development of Dermisphere, an advanced dermal regeneration scaffold product by Fesariustherapeutics Inc. The $349,345 award aims to demonstrate the feasibility of using Dermisphere to manage acute major burn wounds. Preliminary studies have shown that Dermisphere can support rapid and sustained cellular...

This Project Grant award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program will fund the development of an advanced wound care product to treat diabetic foot ulcers. The $305,000 award to Therapeutic Bandage Products, Inc. will support the creation of a patented microneedle bandage that delivers three therapeutic agents to disinfect the wound, prevent bacterial biofilm formation, and attract white blood cells to aid healing. This...

This $100,000 National Science Foundation Technology, Innovation, and Partnerships grant funds the development of tunable porosity aerogel for wound care dressings at The University of Akron from July 1, 2022 to June 30, 2023. The project aims to create a novel bio-based aerogel dressing that could help heal patients with chronic wounds faster by requiring fewer dressing changes. Aerogels' high porosity, surface area and moisture balance properties may create an incubator-like wound healing...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $687,416 Project Grant under CFDA 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research) to Lynntech Inc., a small business technology development company based in College Station, Texas. The grant will support the development of a cutaneous gel to deliver a therapeutic with an intriguing mechanism of action to effectively treat diabetic foot ulcers (DFUs). The project aims to: (1) prepare,...

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $821,426 Project Grant on January 16, 2025 under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to the University of Nebraska Medical Center. The grant supports the development of nanostructures that are selectively targeted to bacteria, with a focus on two pathogens of particular concern: Staphylococcus aureus and Acinetobacter baumannii. The...

This federal Project Grant award of $374,095 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop a device that uses an infrared laser to enable local delivery of a high dose of chemotherapy to the surgical cavity after tumor resection. The technology employs thermosensitive liposomal nanoparticles encapsulating chemotherapy agents that...

Novobiotic Pharmaceuticals, LLC received a $4.5 million Project Grant award from the Defense Health Agency to conduct late-stage preclinical development of the antibiotic teixobactin through April 2026. The funding supports research under the Military Medical Research and Development program, which aims to develop medical solutions for battlefield injuries and infectious diseases. Specifically, the award will allow Novobiotic to advance teixobactin, initially discovered using its iChip...

The National Science Foundation (NSF) awarded a $275,000 Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Auxilium Health, Inc. for the development and validation of an aerogel-based biomaterial wound dressing. The proposed innovation aims to create a multi-layer wound dressing platform with integrated fluid management, biofilm prevention, and rapid infection detection capabilities to improve the management of acute wounds, chronic wounds, surgical...